Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

Peter R. Orszag, the C.E.O. of Lazard, discusses how markets are reacting to the uncertainty of Trump’s tariffs.

Trump’s latest tariff vow threatens to disrupt supplies of obesity drugs such as Mounjaro and Wegovy as pharma giants face ...

U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that ...

President Trump brought up the subject of tariffs for the overseas pharmaceutical industry at a D.C. dinner for Republican ...

Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...

President Donald Trump said his long-promised tariffs on pharmaceutical drugs will be coming soon, the latest signal that he ...

Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Not long after President Donald Trump’s inauguration, the administration’s economic staff went to work on a daunting task: ...

The city’s pharma giants avoided much of the initial turbulence felt by the rest of the economy in the wake of President ...